{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:53:10Z","timestamp":1771656790870,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"University Research Center for Translational Medicine"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,5]]},"abstract":"Abstract<\/jats:title>\n \n STUDY QUESTION<\/jats:title>\n Are the IVF parameters and the steroidogenic luteal characteristics of random-start IVF cycles different from conventional cycles in cancer patients?<\/jats:p>\n <\/jats:sec>\n \n SUMMARY ANSWER<\/jats:title>\n No; controlled ovarian stimulation cycles randomly started at late follicular phase (LFP) and luteal phase (LP) are totally comparable to those conventional IVF cycles started at early follicular phase (EFP) in terms of the expression of the enzymes involved in cholesterol utilization and steroid hormone biosynthesis pathways, gonadotropin receptor expression and, estradiol (E2) and progesterone (P4) production in addition to the similarities in ovarian response to gonadotropin stimulation, oocyte yield, fertilization rate and embryo development competency in cancer patients.<\/jats:p>\n <\/jats:sec>\n \n WHAT IS KNOWN ALREADY<\/jats:title>\n Random start ovarian stimulation protocols are commonly employed for oocyte and embryo freezing for fertility preservation in cancer patients with time constraints who do not have sufficient time to undergo ovarian stimulation initiated conventionally at EFP of the next cycle. No data is available regarding the molecular steroidogenic features of these cycles analyzed together with the clinical IVF characteristics in cancer patients. We aimed to address this question in this study to help understand how similar the random start cycles are to the conventional start ones.<\/jats:p>\n <\/jats:sec>\n \n STUDY DESIGN, SIZE, DURATION<\/jats:title>\n A clinical translational research study conducted in 62 cancer patients undergoing IVF for fertility preservation between the years 2017 and 2022.<\/jats:p>\n <\/jats:sec>\n \n PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n Sixty-two patients who were diagnosed with different types of cancer and underwent ovarian stimulation for oocyte (n\u2009=\u200941) and embryo (n\u2009=\u200921) cryopreservation using GnRH antagonist protocol and human menopausal gonadotropins before receiving cancer treatment\/surgery were enrolled in the study. For patients with breast cancer and endometrial cancer the aromatase inhibitor letrozole was used with gonadotropin stimulation. Ovarian stimulation was initiated conventionally at EFP in 22 patients and served as control while it was started at LFP in 20, and mid-LP in the other 20 patients. The luteinized granulosa cells (GCs) were recovered from follicular aspirates during oocyte retrieval procedure and used for the experiments separately for each individual patient. The expression of the enzymes involved in sex steroid biosynthesis (StAR, 3\u03b2-HSD, Aromatase) and cholesterol synthesis (3-hydroxy 3-methylglutaryl Co-A reductase (HMG-Co-A reductase)), utilization (hormone sensitive lipase (HSL)), and storage (Acetyl-Coenzyme A acetyltransferase 1 (ACAT-1)), and gonadotropin receptor expression status were analyzed using immunoblotting and RT-PCR methods. Laser confocal immunofluorescence imaging was applied to analyze and compare the expression patterns of the steroidogenic enzymes and their relation with mitochondria. In vitro E2 and P4 production by the cells were compared among the groups.<\/jats:p>\n <\/jats:sec>\n \n MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n Baseline demographic and IVF characteristics of the patients undergoing the conventional start and random start IVF cycles were similar. Duration of gonadotropin stimulation was significantly longer in LFP and LP start cycles in comparison to the conventional ones. Ovarian response to gonadotropin stimulation, mature and total oocyte yield, fertilization and Day 5 blastulation rates of the embryos were comparable between the conventional versus random start cycles. When the luteal GCs of these random start cycles were analyzed we could not find any gross differences between these cycles in terms of the viability index and gross light microscopic morphologic features. More detailed analysis of the molecular luteal characteristics of the cells using RT-PCR, immunoblotting methods revealed that the expression profiles of the gonadotropin receptors, and the enzymes involved in sex steroid biosynthesis and cholesterol synthesis\/utilization, and the steroidogenic activity of the luteal GCs of the random start cycles are almost identical to those of the conventional start cycles. Confocal image analysis demonstrated similar patterns in the signal expression profiles of the steroidogenic enzymes and their co-localization within mitochondria.<\/jats:p>\n <\/jats:sec>\n \n LARGE SCALE DATA<\/jats:title>\n N\/A.<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n Caution should be exercised when interpreting our data and counseling cancer patients seeking fertility preservation because it is still unclear if previous exposure to cancer drugs, different ovarian pathologies or infertility etiologies, previous ovarian surgery and\/or any other underlying diseases that are concomitantly present with cancer may cause a difference between conventional and random start stimulation protocols in terms of IVF parameters, luteal function and reproductive outcome. Relatively low number of patients in each stimulation protocol and pooling of luteal GCs for each patient rather than individual analysis of each follicle and oocyte are additional limitations of our study.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n Our findings provide reassurance that random start protocol offers cancer patients an equally good prospect of fertility preservation as conventional IVF.<\/jats:p>\n <\/jats:sec>\n \n STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n Funded by the School of Medicine, the Graduate School of Health Sciences of Koc University and Ko\u00e7 University Research Center for Translational Medicine (KUTTAM), equally funded by the Republic of Turkey Ministry of Development Research Infrastructure Support Program. All authors declare no conflict of interest.<\/jats:p>\n <\/jats:sec>\n \n TRIAL REGISTRATION NUMBER<\/jats:title>\n N\/A.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humrep\/deac242","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T18:01:22Z","timestamp":1668189682000},"page":"113-124","source":"Crossref","is-referenced-by-count":17,"title":["IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patients"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6989-890X","authenticated-orcid":false,"given":"Yashar","family":"Esmaeilian","sequence":"first","affiliation":[{"name":"Research Center for Translational Medicine, Ko\u00e7 University , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9977-1221","authenticated-orcid":false,"given":"Francesko","family":"Hela","sequence":"additional","affiliation":[{"name":"The Graduate School of Health Sciences, Ko\u00e7 University , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7596-2381","authenticated-orcid":false,"given":"Gamze","family":"Bildik","sequence":"additional","affiliation":[{"name":"The Graduate School of Health Sciences, Ko\u00e7 University , Istanbul, Turkey"},{"name":"Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center Present\u00a0address: , Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8321-8499","authenticated-orcid":false,"given":"Nazli","family":"Akin","sequence":"additional","affiliation":[{"name":"Follicle Biology Laboratory (FOBL), Department of Pathology\/Molecular and Cellular Medicine, Vrije Universiteit , Brussel, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9953-3418","authenticated-orcid":false,"given":"Ece","family":"\u0130ltumur","sequence":"additional","affiliation":[{"name":"The Graduate School of Health Sciences, Ko\u00e7 University , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevgi","family":"Yusufoglu","sequence":"additional","affiliation":[{"name":"The Graduate School of Health Sciences, Ko\u00e7 University , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6019-050X","authenticated-orcid":false,"given":"Ceren Sultan","family":"Yildiz","sequence":"additional","affiliation":[{"name":"The Graduate School of Health Sciences, Ko\u00e7 University , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8422-1171","authenticated-orcid":false,"given":"\u0130pek","family":"Keles","sequence":"additional","affiliation":[{"name":"Ko\u00e7 University Hospital Assisted Reproduction Unit , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-7070","authenticated-orcid":false,"given":"Dogan","family":"Vatansever","sequence":"additional","affiliation":[{"name":"Division Gynecological Oncology, Department of Obstetrics and Gynecology, Ko\u00e7 University School of Medicine , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-552X","authenticated-orcid":false,"given":"Cagatay","family":"Taskiran","sequence":"additional","affiliation":[{"name":"Division Gynecological Oncology, Department of Obstetrics and Gynecology, Ko\u00e7 University School of Medicine , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8987-6062","authenticated-orcid":false,"given":"Kayhan","family":"Yakin","sequence":"additional","affiliation":[{"name":"The Graduate School of Health Sciences, Ko\u00e7 University , Istanbul, Turkey"},{"name":"Department of Obstetrics and Gynecology, Ko\u00e7 University School of Medicine , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1966-3886","authenticated-orcid":false,"given":"Ozgur","family":"Oktem","sequence":"additional","affiliation":[{"name":"Research Center for Translational Medicine, Ko\u00e7 University , Istanbul, Turkey"},{"name":"The Graduate School of Health Sciences, Ko\u00e7 University , Istanbul, Turkey"},{"name":"Ko\u00e7 University Hospital Assisted Reproduction Unit , Istanbul, Turkey"},{"name":"Department of Obstetrics and Gynecology, Ko\u00e7 University School of Medicine , Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"2023010801281526000_deac242-B1","doi-asserted-by":"crossref","first-page":"102080","DOI":"10.1016\/j.jogoh.2021.102080","article-title":"Ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts","volume":"50","author":"Alexander","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2023010801281526000_deac242-B2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.fertnstert.2020.07.008","article-title":"Ovarian follicular waves during the menstrual cycle: physiologic insights into novel approaches for ovarian stimulation","volume":"114","author":"Baerwald","year":"2020","journal-title":"Fertil Steril"},{"key":"2023010801281526000_deac242-B3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fendo.2019.00452","article-title":"Human luteinized granulosa cells-A cellular model for the human corpus luteum","volume":"10","author":"Bagnjuk","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023010801281526000_deac242-B4","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/biolre\/ioaa034","article-title":"hCG improves luteal function and promotes progesterone output through the activation of JNK pathway in the luteal granulosa cells of the stimulated IVF cycles","volume":"102","author":"Bildik","year":"2020","journal-title":"Biol Reprod"},{"key":"2023010801281526000_deac242-B5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41420-020-00324-9","article-title":"Terminal differentiation of human granulosa cells as luteinization is reversed by activin-A through silencing of Jnk pathway","volume":"6","author":"Bildik","year":"2020","journal-title":"Cell Death Discov"},{"key":"2023010801281526000_deac242-B6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/humrep\/dey353","article-title":"Luteal granulosa cells from natural cycles are more capable of maintaining their viability, steroidogenic activity and LH receptor expression than those of stimulated IVF cycles","volume":"34","author":"Bildik","year":"2019","journal-title":"Hum Reprod"},{"key":"2023010801281526000_deac242-B7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.fertnstert.2022.01.024","article-title":"Cholesterol uptake or trafficking, steroid biosynthesis, and gonadotropin responsiveness are defective in young poor responders","volume":"117","author":"Bildik","year":"2022","journal-title":"Fertil Steril"},{"key":"2023010801281526000_deac242-B8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10815-016-0721-5","article-title":"Ovarian stimulation in the luteal phase: systematic review and meta-analysis","volume":"33","author":"Boots","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"2023010801281526000_deac242-B9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GCO.0000000000000180","article-title":"Random-start ovarian stimulation in patients with cancer","volume":"27","author":"Cakmak","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2023010801281526000_deac242-B10","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/humrep\/dey217","article-title":"Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle","volume":"33","author":"Cimadomo","year":"2018","journal-title":"Hum Reprod"},{"key":"2023010801281526000_deac242-B11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/1389201018666170808122531","article-title":"Random start ovarian stimulation for oocyte or embryo cryopreservation in women desiring fertility preservation prior to gonadotoxic cancer therapy","volume":"18","author":"Danis","year":"2017","journal-title":"Curr Pharm Biotechnol"},{"key":"2023010801281526000_deac242-B12","first-page":"1","article-title":"ESHRE guideline: female fertility preservation","volume":"4","author":"Anderson","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2023010801281526000_deac242-B13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001703-199906000-00013","article-title":"Culture and transfer of human blastocysts","volume":"11","author":"Gardner","year":"1999","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2023010801281526000_deac242-B14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1472-6483(10)60837-1","article-title":"Highly efficient vitrification method for cryopreservation of human oocytes","volume":"11","author":"Kuwayama","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"2023010801281526000_deac242-B15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2023010801281526000_deac242-B16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12958-020-00570-7","article-title":"Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial","volume":"18","author":"Llacer","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"2023010801281526000_deac242-B17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev"},{"key":"2023010801281526000_deac242-B18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2018.09.007","article-title":"Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: comparison of random start and early follicular phase stimulation - cohort study","volume":"230","author":"Muteshi","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023010801281526000_deac242-B19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/humrep\/dex010","article-title":"FSH Stimulation promotes progesterone synthesis and output from human granulosa cells without luteinization","volume":"32","author":"Oktem","year":"2017","journal-title":"Hum Reprod"},{"key":"2023010801281526000_deac242-B20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1634\/theoncologist.2017-0201","article-title":"Ovarian and uterine functions in female survivors of childhood cancers","volume":"23","author":"Oktem","year":"2018","journal-title":"Oncologist"},{"key":"2023010801281526000_deac242-B21","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.1158\/0008-5472.CAN-07-2042","article-title":"A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve","volume":"67","author":"Oktem","year":"2007","journal-title":"Cancer Res"},{"key":"2023010801281526000_deac242-B22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/humrep\/deaa351","article-title":"Alteration in angiogenic potential of granulosa-lutein cells and follicular fluid contributes to luteal defects in polycystic ovary syndrome","volume":"36","author":"Patil","year":"2021","journal-title":"Hum Reprod"},{"key":"2023010801281526000_deac242-B23","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.fertnstert.2011.01.030","article-title":"Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles","volume":"95","author":"Sonmezer","year":"2011","journal-title":"Fertil Steril"},{"key":"2023010801281526000_deac242-B24","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.fertnstert.2016.03.002","article-title":"Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation","volume":"105","author":"Ubaldi","year":"2016","journal-title":"Fertil Steril"},{"key":"2023010801281526000_deac242-B25","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1093\/humrep\/deaa203","article-title":"The euploid blastocysts obtained after luteal phase stimulation show the same clinical, obstetric and perinatal outcomes as follicular phase stimulation-derived ones: a multicenter study","volume":"35","author":"Vaiarelli","year":"2020","journal-title":"Hum Reprod"},{"key":"2023010801281526000_deac242-B26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10815-022-02409-z","article-title":"Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A","volume":"39","author":"Vaiarelli","year":"2022","journal-title":"J Assist Reprod Genet"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/1\/113\/48445660\/deac242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/38\/1\/113\/48445660\/deac242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T01:29:38Z","timestamp":1673141378000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/38\/1\/113\/6823858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,11,11]]},"published-print":{"date-parts":[[2023,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deac242","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,11,11]]}}}